Terms: = Ovarian cancer AND ER, estrogen receptor AND Prognosis
276 results:
1. A novel CSN5/CRT O-GlcNAc/ER stress regulatory axis in platinum resistance of epithelial ovarian cancer.
Yan T; Ma X; Zhou K; Cao J; Tian Y; Zheng H; Tong Y; Xie S; Wang Y; Guo L; Lu R
Int J Biol Sci; 2024; 20(4):1279-1296. PubMed ID: 38385070
[No Abstract] [Full Text] [Related]
2. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
[TBL] [Abstract] [Full Text] [Related]
3. The management of uterine tumor resembling an ovarian sex cord tumor (UTROSCT): case series and literature review.
Lin J; Liu L; Wang L; Ma N; Zhang K; Xie N; Yu H; Deng S; Sun Y
World J Surg Oncol; 2024 Feb; 22(1):42. PubMed ID: 38310233
[TBL] [Abstract] [Full Text] [Related]
4. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
5. Long-Term Follow-Up of Tamoxifen Treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.
Gideonsson I; Israelsson P; Strandberg SN; Ottander U
Curr Oncol; 2023 Nov; 30(12):10260-10271. PubMed ID: 38132381
[TBL] [Abstract] [Full Text] [Related]
6. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer.
Wang H; Chen C; Wang D; Zhu Y; Chen P
BMC Cancer; 2023 Dec; 23(1):1210. PubMed ID: 38066448
[TBL] [Abstract] [Full Text] [Related]
7. Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
Bae SJ; Kim HJ; Kim HA; Ryu JM; Park S; Lee EG; Im SA; Jung Y; Park MH; Park KH; Kang SH; Park E; Kim SY; Lee MH; Kim LS; Lee A; Noh WC; Gwark S; Kim S; Jeong J
Int J Surg; 2024 Feb; 110(2):934-942. PubMed ID: 38000057
[TBL] [Abstract] [Full Text] [Related]
8. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Wang Y; Broeks A; Giardiello D; Hauptmann M; Jóźwiak K; Koop EA; Opdam M; Siesling S; Sonke GS; Stathonikos N; Ter Hoeve ND; van der Wall E; van Deurzen CHM; van Diest PJ; Voogd AC; Vreuls W; Linn SC; Dackus GMHE; Schmidt MK
Eur J Cancer; 2023 Dec; 195():113401. PubMed ID: 37925965
[TBL] [Abstract] [Full Text] [Related]
9. Endoplasmic Reticulum Stress-Related Ten-Biomarker Risk Classifier for Survival Evaluation in Epithelial ovarian cancer and
Zhang M; Wang Y; Xu S; Huang S; Wu M; Chen G; Wang Y
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762313
[TBL] [Abstract] [Full Text] [Related]
10. High-grade serous ovarian carcinoma, the "Achiles' hill" for clinicians and molecular biologists: a molecular insight.
Bhattacharya R; Ghosh A; Mukhopadhyay S
Mol Biol Rep; 2023 Nov; 50(11):9511-9519. PubMed ID: 37737967
[TBL] [Abstract] [Full Text] [Related]
11. The Application of 18 F-FES PET in Clinical cancer Care : A Systematic Review.
Huang YT; Chen TW; Chen LY; Huang YY; Lu YS
Clin Nucl Med; 2023 Sep; 48(9):785-795. PubMed ID: 37482660
[TBL] [Abstract] [Full Text] [Related]
12. In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone receptors in BRCA1-Associated Breast cancers.
Santarosa M; Baldazzi D; Armellin M; Maestro R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373065
[TBL] [Abstract] [Full Text] [Related]
13. Distinct histological and clinical features associated with pure uterine serous carcinoma: A single institution experience.
Zhi W; Zhan Y; He C; Jin Y
Ann Diagn Pathol; 2023 Oct; 66():152173. PubMed ID: 37352704
[TBL] [Abstract] [Full Text] [Related]
14. Primary ovarian Small Cell Carcinoma of Pulmonary Type: Analysis of 6 Cases and Review of 31 Cases in the Literatures.
Chen X; Liu HL; Wang JS; Zhao FH
Chin Med Sci J; 2023 Jun; 38(2):130-137. PubMed ID: 37286512
[TBL] [Abstract] [Full Text] [Related]
15. Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
Reichenbach J; Fraungruber P; Mayr D; Buschmann C; Kraus FBT; Topalov NE; Chelariu-Raicu A; Kolben T; Burges A; Mahner S; Kessler M; Jeschke U; Czogalla B; Trillsch F
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8719-8728. PubMed ID: 37131060
[TBL] [Abstract] [Full Text] [Related]
16. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive cancers: Breast cancer, Cervical cancer, Endometrial cancer, ovarian cancer and Prostate cancer.
Korbecki J; Bosiacki M; Barczak K; Łagocka R; Brodowska A; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108425
[TBL] [Abstract] [Full Text] [Related]
17. ERβ in Granulosa Cell Tumors and Its Clinical Potential.
Birgersson M; Indukuri R; Antonson P; Nalvarte I; Archer A; Williams C
Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37075218
[TBL] [Abstract] [Full Text] [Related]
18. The prognostic value and biological functions of
Ying Y; Meng Y; Bian L; Zhang M; Zhou P; Zhang S; Wang W; Yao Y; Ren Q; Li D
Epigenomics; 2023 Feb; 15(3):147-166. PubMed ID: 37020390
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The cancer Genome Atlas-like Prognostic Subgroups.
Irshaid L; Costigan DC; Dong F; Matulonis UA; Nucci MR; Kolin DL
Mod Pathol; 2023 May; 36(5):100123. PubMed ID: 36857998
[TBL] [Abstract] [Full Text] [Related]
[Next]
